New flu vaccine trial aims to protect moms and babies

NCT ID NCT07211152

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new flu vaccine in 150 healthy pregnant women aged 18-39, between 20 and 32 weeks of pregnancy. Participants receive either the new vaccine or an existing one, and researchers check immune response and safety for both mother and baby. The goal is to see if the vaccine protects against flu and passes protection to the newborn.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLUENZA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Health Cube Medical Clinics

    RECRUITING

    Mandaluyong, National Capital Region, Philippines

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of the Philippines - Philippine General Hospital (UP-PGH)

    RECRUITING

    Manila, National Capital Region, Philippines

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.